| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-12 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-11 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |